117 related articles for article (PubMed ID: 8980865)
1. Treatment of multidrug-resistant tuberculosis in Indonesia.
Hadiarto M; Tjandra YA; Hudoyo A
Chemotherapy; 1996; 42 Suppl 3():24-9. PubMed ID: 8980865
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multidrug-resistant tuberculosis in Thailand.
Maranetra KN
Chemotherapy; 1996; 42 Suppl 3():10-5; discussion 30-3. PubMed ID: 8980862
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
Yew WW; Chan CK; Chau CH; Tam CM; Leung CC; Wong PC; Lee J
Chest; 2000 Mar; 117(3):744-51. PubMed ID: 10713001
[TBL] [Abstract][Full Text] [Related]
4. Treatment of multidrug-resistant tuberculosis in Taiwan.
Suo J; Yu MC; Lee CN; Chiang CY; Lin TP
Chemotherapy; 1996; 42 Suppl 3():20-3; discussion 30-3. PubMed ID: 8980864
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of low-dose ofloxacin in the treatment of multidrug-resistant tuberculosis in Indonesia.
Mangunnegoro H; Hudoyo A
Chemotherapy; 1999; 45 Suppl 2():19-25. PubMed ID: 10449894
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
7. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
[TBL] [Abstract][Full Text] [Related]
8. Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis.
Lee H; Ahn S; Hwang NY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Kim CK; Koh WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203478
[TBL] [Abstract][Full Text] [Related]
9. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
[TBL] [Abstract][Full Text] [Related]
10. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; Cardaño RC; Derilo JO; Belen VA
Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582
[TBL] [Abstract][Full Text] [Related]
11. Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China.
Zheng X; Zheng R; Hu Y; Werngren J; Forsman LD; Mansjö M; Xu B; Hoffner S
Antimicrob Agents Chemother; 2016 Aug; 60(8):4786-92. PubMed ID: 27246779
[TBL] [Abstract][Full Text] [Related]
12. Quinolones and multidrug-resistant tuberculosis.
Maranetra KN
Chemotherapy; 1999; 45 Suppl 2():12-8. PubMed ID: 10449893
[TBL] [Abstract][Full Text] [Related]
13. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
14. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
15. Ofloxacin in multidrug resistant tuberculosis.
Walwaikar PP; Morye VK; Gawde AS
J Indian Med Assoc; 2003 Mar; 101(3):210-2. PubMed ID: 14603981
[TBL] [Abstract][Full Text] [Related]
16. High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India.
Selvakumar N; Kumar V; Balaji S; Prabuseenivasan S; Radhakrishnan R; Sekar G; Chandrasekaran V; Kannan T; Thomas A; Arunagiri S; Dewan P; Swaminathan S
PLoS One; 2015; 10(3):e0117421. PubMed ID: 25738956
[TBL] [Abstract][Full Text] [Related]
17. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
Singhal P; Dixit P; Singh P; Jaiswal I; Singh M; Jain A
Indian J Med Res; 2016 Mar; 143(3):341-7. PubMed ID: 27241648
[TBL] [Abstract][Full Text] [Related]
18. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru.
Campos PE; Suarez PG; Sanchez J; Zavala D; Arevalo J; Ticona E; Nolan CM; Hooton TM; Holmes KK
Emerg Infect Dis; 2003 Dec; 9(12):1571-8. PubMed ID: 14720398
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.
Pracharktam R; Angkananukool K; Vibhagool A
J Med Assoc Thai; 2001 Sep; 84(9):1241-5. PubMed ID: 11800295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
